Skip to Content

Zyprexa Relprevv Approval History

  • FDA approved: Yes (First approved December 11th, 2009)
  • Brand name: Zyprexa Relprevv
  • Generic name: olanzapine
  • Dosage form: for Extended Release Injectable Suspension
  • Company: Lilly
  • Treatment for: Schizophrenia

Zyprexa Relprevv (olanzapine) is a long-acting atypical antipsychotic for intramuscular injection indicated for the treatment of schizophrenia.

Development History and FDA Approval Process for Zyprexa Relprevv

Dec 14, 2009Approval FDA Approves Lilly's Zyprexa Relprevv for Treatment of Schizophrenia in Adults

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.